Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer

Journal of Urology

Volumn 171, Issue 1, 2004, Pages 187-191

  Stephan, Carsten ^b   Yousef, George M ^b   Scorilas, Andreas ^b   Jung, Klaus ^b   Jung, Monika ^b   Kristiansen, Glen ^b   Hauptmann, Steffen ^b   Kishi, Tadaaki ^b   Nakamura, Terukazu ^b   Loening, Stefan A ^b   Diamandis, Eleftherios P ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NONE

Author keywords

Hepsin; Prostate; Prostatic neoplasms; Serine endopeptidases; Tumor markers, biological

Indexed keywords

BETA ACTIN; COMPLEMENTARY DNA; HEPSIN; PROTEIN; SERINE PROTEINASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CALCULATION; CANCER RECURRENCE; DISEASE MARKER; DNA MICROARRAY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 10744220367     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000101622.74236.94     Document Type: Article

References (20)

1. Polascik, T. J., Oesterling, J. E. and Partin, A. W.: Prostate specific antigen: a decade of discovery-what we have learned and where we are going. J Urol, 162: 293, 1999
2. Lilja, H., Christensson, A., Dahlen, U., Matikainen, M. T., Nilsson, O., Pettersson, K. et al: Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem, 37: 1618, 1991
3. Stenman, U. H., Leinonen, J., Alfthan, H., Rannikko, S., Tuhkanen, K. and Alfthan, O.: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res, 51: 222, 1991
4. Nam, R. K., Diamandis, E. P., Toi, A., Trachtenberg, J., Magklara, A., Scorilas, A. et al: Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen. J Clin Oncol, 18: 1036, 2000
5. Stamey, T. A.: Preoperative serum prostate-specific antigen (PSA) below 10 microg/l predicts neither the presence of prostate cancer nor the rate of postoperative PSA failure. Clin Chem, 47: 631, 2001
6. Stamey, T. A., Warrington, J. A., Caldwell, M. C., Chen, Z., Fan, Z., Mahadevappa, M. et al: Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. J Urol, 166: 2171, 2001
7. Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K. et al: Delineation of prognostic biomarkers in prostate cancer. Nature, 412: 822, 2001
8. Magee, J. A., Araki, T., Patil, S., Ehrig, T., True, L., Humphrey, P. A. et al: Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res, 61: 5692, 2001
9. Welsh, J. B., Sapinoso, L. M., Su, A. I., Kern, S. G., Wang-Rodriguez, J., Moskaluk, C. A. et al: Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res, 61: 5974, 2001
10. Meyer, A., Jung, K., Lein, M., Rudolph, B., Schnorr, D. and Loening, S. A.: Factors influencing the ratio of free to total prostate-specific antigen in serum. Int J Cancer, 74: 630, 1997
11. Wittwer, C. T., Ririe, K. M., Andrew, R. V., David, D. A., Gundry, R. A. and Balis, U. J.: The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques, 22: 176, 1997
12. Yousef, G. M., Kyriakopoulou, L. G., Scorilas, A., Fracchioli, S., Ghiringhello, B., Zarghooni, M. et al: Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker. Cancer Res, 61: 7811, 2001
13. Leytus, S. P., Loeb, K. R., Hagen, F. S., Kurachi, K. and Davie, E. W.: A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells. Biochemistry, 27: 1067, 1988
14. Tsuji, A., Torres-Rosado, A., Arai, T., Chou, S. H. and Kurachi, K.: Characterization of hepsin, a membrane bound protease. Biomed Biochim Acta, 50: 791, 1991
15. Tsuji, A., Torres-Rosado, A., Arai, T., Le Beati, M. M., Lemons, R. S., Chou, S. H. et al: Hepsin, a cell membrane-associated protease. Characterization, tissue distribution, and gene localization. J Biol Chem, 266: 16948, 1991
16. Torres-Rosado, A., O'Shea, K. S., Tsuji, A., Chou, S. H. and Kurachi, K.: Hepsin, a putative cell-surface serine protease, is required for mammalian cell growth. Proc Natl Acad Sci USA, 90: 7181, 1993
17. Kazama, Y., Hamamoto, T., Foster, D. C. and Kisiel, W.: Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation. J Biol Chem, 270: 66, 1995
18. Vu, T. K., Liu, R. W., Haaksma, C. J., Tomasek, J. J. and Howard, E. W.: Identification and cloning of the membrane-associated serine protease, hepsin, from mouse preimplantation embryos. J Biol Chem, 272: 31315, 1997
19. Zacharski, L. R., Ornstein, D. L., Memoli, V. A., Rousseau, S. M. and Kisiel, W.: Expression of the factor VII activating protease, hepsin, in situ in renal cell carcinoma. Thromb Haemost, 79: 876, 1998
20. Tanimoto, H., Yan, Y., Clarke, J., Korourian, S., Shigemasa, K., Parmley, T. H. et al: Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. Cancer Res, 57: 2884, 1997